statut,statut_label,NCTId,eudraCT,CTIS,completion_year,clinical_trial_title,acronym,results_1y,results_3y,results,intervention_type
ðŸŸ§,orange,NCT01360242,,,2013,Patients Presenting With Acute STEMI Treated With Primary PCI : Comparison of the Impact of the MIMI Approach With a Conventional Strategy of Immediate Stenting,MIMI,False,True,True,PROCEDURE
â¬›,noir,NCT02735005,,,2017,"Epidemiology of Aging of People With Disabilities - Gerontological Sector ""Rumilly-Annecy-Saint-Julien-Pays de Gex-Bellegarde"" : Description of the Population in an Attempt to Identify Ways to Implement to Meet the Needs in Aging",PHV,False,False,False,OTHER
â¬›,noir,NCT04089397,,,2020,Randomized Open-label Trial Evaluating Light Therapy on Sleep Quality in Dialysis Patients,LUMIDIAL,False,False,False,DEVICE
â¬›,noir,NCT03493750,,,2021,"Oral Evaluation by the Nurses From the Office of Access to Healthcare (""PASS"") for Vulnerable People as a Vector for the Detection of Oral Diseases to Improve Access to the Appropriate Healthcare Branch - PASSDENT Study",PASSDENT,False,False,False,OTHER
ðŸŸ§,orange,NCT05154383,2021-004573-32,,2022,"Effect of High-Dose Quadrivalent Influenza Vaccine (EflueldaÂ®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression",INFLUOMICS,False,True,True,BIOLOGICAL
â¬›,noir,,2018-001105-85,,2023,"A multicenter phase II study evaluating denosumab (XGEVAÂ®) in combination with nivolumab (OPDIVOÂ®) as second-line therapy for patients with stage IV non-smallâ€“cell lung cancer (squamous and non-squamous) with bone metastases 
 
 
 Etude de phase II multicentrique de lâ€™Ã©valuation du denosumab (XGEVAÂ®) associÃ© au nivolumab (OPDIVOÂ®) en 2Ã¨me ligne de traitement chez des patients prÃ©sentant un cancer bronchique non Ã  petites cellules (Ã©pidermoÃ¯de et non Ã©pidermoÃ¯de) de stade IV, porteurs de mÃ©tastases osseuses","DENIVOS 
 
 
 DENIVOS",False,False,False,
